Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia

Leuel Lisanwork Arage, Haji Aman Deybasso, Delelegn Yilma Gebremichael, Binyam Gintamo Nuramo, Zelalem Negash Mekuria

Open source

DOI
10.2147/hiv.s300135
Published
2021-03
Container
HIV/AIDS - Research and Palliative Care
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/hiv.s300135,
  title = {Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia},
  author = {Leuel Lisanwork Arage and Haji Aman Deybasso and Delelegn Yilma Gebremichael and Binyam Gintamo Nuramo and Zelalem Negash Mekuria},
  year = {2021},
  journal = {HIV/AIDS - Research and Palliative Care},
  doi = {10.2147/hiv.s300135},
  url = {https://doi.org/10.2147/hiv.s300135}
}

RIS

TY  - JOUR
TI  - Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
AU  - Leuel Lisanwork Arage
AU  - Haji Aman Deybasso
AU  - Delelegn Yilma Gebremichael
AU  - Binyam Gintamo Nuramo
AU  - Zelalem Negash Mekuria
PY  - 2021
JO  - HIV/AIDS - Research and Palliative Care
DO  - 10.2147/hiv.s300135
UR  - https://doi.org/10.2147/hiv.s300135
ER  - 

APA

Arage, L. L., Deybasso, H. A., Gebremichael, D. Y., Nuramo, B. G., & Mekuria, Z. N. (2021). Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia. HIV/AIDS - Research and Palliative Care. https://doi.org/10.2147/hiv.s300135

Source records